Washington Trust Bancorp, Inc. (WASH)
NASDAQ: WASH · Real-Time Price · USD
26.43
-0.51 (-1.89%)
At close: Aug 1, 2025, 4:00 PM
26.42
-0.01 (-0.04%)
After-hours: Aug 1, 2025, 5:44 PM EDT
CTI BioPharma Stock Forecast
Stock Price Forecast
The 4 analysts that cover CTI BioPharma stock have a consensus rating of "Buy" and an average price target of $32.25, which forecasts a 22.02% increase in the stock price over the next year. The lowest target is $28 and the highest is $36.
Price Target: $32.25 (+22.02%)
Analyst Consensus: Buy
* Price targets were last updated on May 28, 2025.
Analyst Ratings
The average analyst rating for CTI BioPharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Initiates $28 | Hold | Initiates | $28 | +5.94% | May 28, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $34 → $31 | Hold | Maintains | $34 → $31 | +17.29% | Apr 22, 2025 |
| Seaport Global | Seaport Global | Hold → Strong Buy Upgrades $36 | Hold → Strong Buy | Upgrades | $36 | +36.21% | Mar 14, 2025 |
| Piper Sandler | Piper Sandler | Sell → Hold Upgrades $30 → $34 | Sell → Hold | Upgrades | $30 → $34 | +28.64% | Oct 22, 2024 |
| Seaport Global | Seaport Global | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 31, 2024 |
Financial Forecast
Revenue This Year
155.17M
from 98.25M
Increased by 57.93%
Revenue Next Year
206.01M
from 155.17M
Increased by 32.76%
EPS This Year
2.68
from -1.63
EPS Next Year
3.11
from 2.68
Increased by 16.07%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 159.9M | 248.7M |
| Avg | 155.2M | 206.0M |
| Low | 148.9M | 163.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 62.8% | 60.3% |
| Avg | 57.9% | 32.8% |
| Low | 51.6% | 5.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 2.87 | 3.32 |
| Avg | 2.68 | 3.11 |
| Low | 2.44 | 2.90 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 23.8% |
| Avg | - | 16.1% |
| Low | - | 8.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.